This paper reported the diagnosis and treatment of a case of inguinal ectopic pregnancy. The patient, a 34-year-old female, had her last menstrual period on June 28, 2024. After amenorrhea, serum human chorionic gonadotropin (hCG) levels continued to rise (the highest was 13 193 U/L). However, repeated transvaginal ultrasound examinations failed to locate the implantation site of the gestational sac. Given the patient's inguinal pain, focused ultrasonography was performed in the inguinal region, revealing an ectopic pregnancy mass, which was subsequently surgically removed. Pathological analysis confirmed the diagnosis of inguinal ectopic pregnancy.

This paper reported the diagnosis and treatment of a case of inguinal ectopic pregnancy. The patient, a 34-year-old female, had her last menstrual period on June 28, 2024. After amenorrhea, serum human chorionic gonadotropin (hCG) levels continued to rise (the highest was 13 193 U/L). However, repeated transvaginal ultrasound examinations failed to locate the implantation site of the gestational sac. Given the patient's inguinal pain, focused ultrasonography was performed in the inguinal region, revealing an ectopic pregnancy mass, which was subsequently surgically removed. Pathological analysis confirmed the diagnosis of inguinal ectopic pregnancy.

Calcific aortic valve disease(CAVD)is the most common disease affecting the heart valves,character-ized by thickening,fibrosis,and mineralization of the aortic valve leaflets.Currently,there is no effective pharmacologi-cal treatment.Aortic valve calcification is a complex and multifactorial process involving valve inflammation,fibrosis,calcification,valve thickening and outflow tract obstruction.The exact pathophysiological mechanisms of CAVD are not fully understood,but many studies have suggested that innate immune cells play a key role in the development of aortic valve calcification.This review focuses on the current role of innate immune cells in the development of CAVD.

Abivertinib, a third-generation tyrosine kinase inhibitor, is originally designed to target epidermal growth factor receptor (EGFR)-activating mutations. Previous studies have shown that abivertinib has promising antitumor activity and a well-tolerated safety profile in patients with non-small-cell lung cancer. However, abivertinib also exhibited high inhibitory activity against Bruton's tyrosine kinase and Janus kinase 3. Given that these kinases play some roles in the progression of megakaryopoiesis, we speculate that abivertinib can affect megakaryocyte (MK) differentiation and platelet biogenesis. We treated cord blood CD34⁺ hematopoietic stem cells, Meg-01 cells, and C57BL/6 mice with abivertinib and observed megakaryopoiesis to determine the biological effect of abivertinib on MK differentiation and platelet biogenesis. Our in vitro results showed that abivertinib impaired the CFU-MK formation, proliferation of CD34⁺ HSC-derived MK progenitor cells, and differentiation and functions of MKs and inhibited Meg-01-derived MK differentiation. These results suggested that megakaryopoiesis was inhibited by abivertinib. We also demonstrated in vivo that abivertinib decreased the number of MKs in bone marrow and platelet counts in mice, which suggested that thrombopoiesis was also inhibited. Thus, these preclinical data collectively suggested that abivertinib could inhibit MK differentiation and platelet biogenesis and might be an agent for thrombocythemia.
Acrylamides/pharmacology* ; Animals ; Blood Platelets/drug effects* ; Cell Differentiation ; Megakaryocytes/drug effects* ; Mice ; Mice, Inbred C57BL ; Piperazines/pharmacology* ; Pyrimidines/pharmacology*

Congenital hydrocephalus is a major neurological disorder with high rates of morbidity and mortality; however, the underlying cellular and molecular mechanisms remain largely unknown. Reproducible animal models mirroring both embryonic and postnatal hydrocephalus are also limited. Here, we describe a new mouse model of congenital hydrocephalus through knockout of β-catenin in Nkx2.1-expressing regional neural progenitors. Progressive ventriculomegaly and an enlarged brain were consistently observed in knockout mice from embryonic day 12.5 through to adulthood. Transcriptome profiling revealed severe dysfunctions in progenitor maintenance in the ventricular zone and therefore in cilium biogenesis after β-catenin knockout. Histological analyses also revealed an aberrant neuronal layout in both the ventral and dorsal telencephalon in hydrocephalic mice at both embryonic and postnatal stages. Thus, knockout of β-catenin in regional neural progenitors leads to congenital hydrocephalus and provides a reproducible animal model for studying pathological changes and developing therapeutic interventions for this devastating disease.
Animals ; Disease Models, Animal ; Hydrocephalus/genetics* ; Mice ; Mice, Knockout ; Neurons ; beta Catenin/genetics*

Objective:To investigate the effects of early hyperbaric oxygen combined with piracetam on hepatic and renal function and myocardial enzyme spectrum in patients with acute carbon monoxide poisoning (ACOP).Methods:A total of 103 patients with ACOP treated in the Emergency Department of Affiliated Hospital of Jining Medical University from January 2015 to January 2019 were selected and divided into control group (53 cases, hyperbaric oxygen treatment) and observation group (50 cases, hyperbaric oxygen combined with piracetam treatment). The changes in the renal function, myocardial enzyme spectrum, superoxide dismutase (SOD), and the hepatic function, as well as the clinical efficacy, and the incidences of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group (98.00%) was significantly higher than that of the control group (79.25%), and there was a statistically significant difference ( P<0.05). After treatment, the levels of blood urea nitrogen (BUN), creatinine (Cr), uric acid, β2 microglobulin (β2-MG), creatine kinase (CK), creatine kinase isoenzyme (CK-MB), α-hydroxybutyrate dehydrogenase (α-HBDH), lactate dehydrogenase (LDH), alkaline phosphatase (ALP), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) in the observation group were lower than those in the control group, while the level of SOD in the observation group was higher than that in the control group, and there were statistically significant differences ( P<0.05). In terms of the incidences of delayed encephalopathy, acute cerebral infarction, rhabdomyolysis, and pressure ulcer, there was no statistically significant difference between the two groups ( P>0.05). Conclusion:The early hyperbaric oxygen combined with piracetam has a significant clinical efficacy in treating patients with ACOP. It can alleviate the myocardial damage caused by hypoxia, and plays a positive role in protecting hepatic and renal function.

Objective:To investigate the effects of early hyperbaric oxygen combined with piracetam on hepatic and renal function and myocardial enzyme spectrum in patients with acute carbon monoxide poisoning (ACOP).Methods:A total of 103 patients with ACOP treated in the Emergency Department of Affiliated Hospital of Jining Medical University from January 2015 to January 2019 were selected and divided into control group (53 cases, hyperbaric oxygen treatment) and observation group (50 cases, hyperbaric oxygen combined with piracetam treatment). The changes in the renal function, myocardial enzyme spectrum, superoxide dismutase (SOD), and the hepatic function, as well as the clinical efficacy, and the incidences of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group (98.00%) was significantly higher than that of the control group (79.25%), and there was a statistically significant difference ( P<0.05). After treatment, the levels of blood urea nitrogen (BUN), creatinine (Cr), uric acid, β2 microglobulin (β2-MG), creatine kinase (CK), creatine kinase isoenzyme (CK-MB), α-hydroxybutyrate dehydrogenase (α-HBDH), lactate dehydrogenase (LDH), alkaline phosphatase (ALP), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) in the observation group were lower than those in the control group, while the level of SOD in the observation group was higher than that in the control group, and there were statistically significant differences ( P<0.05). In terms of the incidences of delayed encephalopathy, acute cerebral infarction, rhabdomyolysis, and pressure ulcer, there was no statistically significant difference between the two groups ( P>0.05). Conclusion:The early hyperbaric oxygen combined with piracetam has a significant clinical efficacy in treating patients with ACOP. It can alleviate the myocardial damage caused by hypoxia, and plays a positive role in protecting hepatic and renal function.

Objective? To establish a digital protection system for incontinence-associated dermatitis based on earlier prevention to reduce the incidence of incontinence-associated dermatitis. Methods? Based on the informationization of nursing platform, we run the digital protection system module of incontinence-related dermatitis based on the forward moving of the prevention gateway in Zhejiang Provincial People＇s Hospital. Through comparative study, 108 patients with incontinence and incontinence-related dermatitis from January to March 2018 were randomly selected as the pre-operation data, and 108 patients with incontinence and incontinence-related dermatitis from January to March 2019 as the post-operation data. The nurses of the two groups were observed and compared in terms of their assessment accuracy in patients＇ incontinence risk, position and Incontinence Associated Dermatitis Severity(IADS), clinical staging, and implementation of prevention strategies. Meanwhile, the incidence of incontinence-related dermatitis among all inpatients in the hospital from January to March in 2018 was compared with the same period of 2019. Results? After the operation of the digital protection system for incontinence-related dermatitis based on earlier prevention, the nursing staff's accuracy rate in the risk assessment of incontinence (χ2=38.095,P＜0.01), IADS (χ2=64.901,P＜0.01), clinical staging accuracy (χ2=42.424,P＜0.01) and the implementation of protective measures (χ2=50.000, P＜0.01) had significant statistical differences. The incidence of incontinence-related dermatitis in hospitalized patients decreased from 0.35% before operation to 0.06% after operation with statistical significance(χ2=41.031, P＜0.01). Conclusions? The operation of the digital protection system for incontinence-associated dermatitis based on earlier prevention can reduce the incidence of incontinence-associated dermatitis and improve the prevention and management competence of nursing staff.